94 related articles for article (PubMed ID: 15452270)
1. Four EBNA2 domains are important for EBNALP coactivation.
Peng CW; Zhao B; Kieff E
J Virol; 2004 Oct; 78(20):11439-42. PubMed ID: 15452270
[TBL] [Abstract][Full Text] [Related]
2. Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation.
Peng CW; Xue Y; Zhao B; Johannsen E; Kieff E; Harada S
Proc Natl Acad Sci U S A; 2004 Jan; 101(4):1033-8. PubMed ID: 14732686
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
J Virol; 2018 May; 92(9):. PubMed ID: 29467311
[TBL] [Abstract][Full Text] [Related]
4. Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2.
Peng CW; Zhao B; Chen HC; Chou ML; Lai CY; Lin SZ; Hsu HY; Kieff E
Blood; 2007 Jun; 109(12):5447-54. PubMed ID: 17341665
[TBL] [Abstract][Full Text] [Related]
5. Conditional expression of a dominant-negative form of Epstein-Barr virus (EBV) nuclear antigen EBNALP inhibits EBV-positive lymphoblastoid cell growth.
Harada S; Saijo M
Arch Virol; 2020 Feb; 165(2):313-320. PubMed ID: 31813023
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4.
Portal D; Rosendorff A; Kieff E
Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19278-83. PubMed ID: 17159145
[TBL] [Abstract][Full Text] [Related]
7. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.
Portal D; Zhao B; Calderwood MA; Sommermann T; Johannsen E; Kieff E
Proc Natl Acad Sci U S A; 2011 May; 108(19):7808-13. PubMed ID: 21518914
[TBL] [Abstract][Full Text] [Related]
8. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
[TBL] [Abstract][Full Text] [Related]
9. Phase Separation of Epstein-Barr Virus EBNA2 and Its Coactivator EBNALP Controls Gene Expression.
Peng Q; Wang L; Qin Z; Wang J; Zheng X; Wei L; Zhang X; Zhang X; Liu C; Li Z; Wu Y; Li G; Yan Q; Ma J
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941785
[TBL] [Abstract][Full Text] [Related]
10. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes.
Zimber-Strobl U; Strobl LJ
Semin Cancer Biol; 2001 Dec; 11(6):423-34. PubMed ID: 11669604
[TBL] [Abstract][Full Text] [Related]
11. The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenance.
Gordadze AV; Poston D; Ling PD
J Virol; 2002 Jul; 76(14):7349-55. PubMed ID: 12072534
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus nuclear antigen 2 binds via its methylated arginine-glycine repeat to the survival motor neuron protein.
Barth S; Liss M; Voss MD; Dobner T; Fischer U; Meister G; Grässer FA
J Virol; 2003 Apr; 77(8):5008-13. PubMed ID: 12663808
[TBL] [Abstract][Full Text] [Related]
13. Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.
Ponnusamy R; Khatri R; Correia PB; Wood CD; Mancini EJ; Farrell PJ; West MJ
PLoS Pathog; 2019 Jul; 15(7):e1007458. PubMed ID: 31283782
[TBL] [Abstract][Full Text] [Related]
14. EBNA3C coactivation with EBNA2 requires a SUMO homology domain.
Rosendorff A; Illanes D; David G; Lin J; Kieff E; Johannsen E
J Virol; 2004 Jan; 78(1):367-77. PubMed ID: 14671118
[TBL] [Abstract][Full Text] [Related]
15. BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.
Harter MR; Liu CD; Shen CL; Gonzalez-Hurtado E; Zhang ZM; Xu M; Martinez E; Peng CW; Song J
PLoS Pathog; 2016 Feb; 12(2):e1005414. PubMed ID: 26845565
[TBL] [Abstract][Full Text] [Related]
16. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
Gross H; Hennard C; Masouris I; Cassel C; Barth S; Stober-Grässer U; Mamiani A; Moritz B; Ostareck D; Ostareck-Lederer A; Neuenkirchen N; Fischer U; Deng W; Leonhardt H; Noessner E; Kremmer E; Grässer FA
PLoS One; 2012; 7(8):e42106. PubMed ID: 22879910
[TBL] [Abstract][Full Text] [Related]
17. Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin.
Alazard N; Gruffat H; Hiriart E; Sergeant A; Manet E
J Virol; 2003 Jul; 77(14):8166-72. PubMed ID: 12829856
[TBL] [Abstract][Full Text] [Related]
18. EBNA2 and activated Notch induce expression of BATF.
Johansen LM; Deppmann CD; Erickson KD; Coffin WF; Thornton TM; Humphrey SE; Martin JM; Taparowsky EJ
J Virol; 2003 May; 77(10):6029-40. PubMed ID: 12719594
[TBL] [Abstract][Full Text] [Related]
19. Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.
Lucchesi W; Brady G; Dittrich-Breiholz O; Kracht M; Russ R; Farrell PJ
J Virol; 2008 Aug; 82(15):7456-66. PubMed ID: 18480445
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.
Kempkes B; Zimber-Strobl U; Eissner G; Pawlita M; Falk M; Hammerschmidt W; Bornkamm GW
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():227-37. PubMed ID: 8627226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]